Sana Biotechnology, Inc. (SANA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Company Overview - Sana is approximately 6 to 7 years old and was founded with the vision of transforming medicine through gene modification and using cells as therapies [3] - The company aims to establish itself as a leading entity in the evolving field of cell and gene therapy [3] Industry Context - The cell and gene therapy sector is currently facing a challenging operating environment, which the company acknowledges [3] - Despite these challenges, the fundamental belief in the transformative potential of gene modification and cell-based therapies remains strong [3]